Ionis Provides Improved 2017 Guidance Following Strong Financial Performance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. KTOS
4. PLTR
5. SPY
6. AON
7. TMUS
8. LBRX
9. BMY
10. MRK

Go back to Ionis Provides Improved 2017 Guidance Following Strong Financial Performance

Ionis Pharmaceuticals (IONS) PT Raised to $50 at Stifel; Reiterates Hold

August 9, 2017 7:08 AM EDT

Stifel raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $50.00 (from $42.00) while maintaining a Hold rating following the company's 2Q. IONS reported a net loss of $(0.09)/share, narrowly missing Consensus estimates for $(0.11). Higher-than-estimated revenues of $105M drove most of the beat,... More

Ionis Pharma (IONS) Reports Q2 Loss of $0.09/Share

August 8, 2017 7:11 AM EDT

Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.09), versus ($0.47) reported last year. Revenue for the quarter came in at $104.2 million, versus $38.5 million reported last year.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

... More